<DOC>
	<DOCNO>NCT01910636</DOCNO>
	<brief_summary>This study evaluate antiviral efficacy , safety , tolerability sofosbuvir ( SOF ) plus ribavirin ( RBV ) Japanese participant chronic genotype 2 hepatitis C virus ( HCV ) infection .</brief_summary>
	<brief_title>Efficacy Safety Sofosbuvir Plus Ribavirin Japanese Adults With Chronic Genotype 2 HCV Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Chronic genotype 2 HCVinfection Male female , age ≥ 20 year Body weight ≥ 40 kg HCV RNA ≥ 10,000 IU/mL screen Current prior history clinically significant illness HCV Pregnant nurse female male pregnant female partner Chronic liver disease nonHCV etiology Infection hepatitis B virus ( HBV ) human immunodeficiency virus ( HIV )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>HCV genotype 2 ( GT-2 )</keyword>
</DOC>